Concepedia

Aparna Hegde

AH

Statistics

Publications

22

Citations

4.8K

H-Index

18

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Huntsman Cancer Institute

University of Alabama at Birmingham

Memorial Sloan Kettering Cancer Center

University of Utah

Aparna Hegde is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2012–2025

22

Publications

22

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.4K citations

, , +16

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1K citations · Full text

, , +17

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 827 citations · Full text

, , +17

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2023 · 483 citations · Full text

, , +16

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Chipman Stroud, Aparna Hegde, Cynthia R. Cherry et al. · Journal of Oncology Pharmacy Practice · 2017 · 328 citations

, , +17

1–5 of 22